More revenue, more jobs, more financing, more R&D expenditure – all signs point towards sustainable growth in...
Up To Date
Latest News
An expert panel’s final report on the fatal drug trial earlier this year in France states that the death of...
For up to US$685m (€606m), Dutch ArgenX has outlicensed its human antibody programme ARGX-115 to AbbVie. The...
Despite political disturbances, 2015 was a good year for the biotech scene in Switzerland. Net sales increased...
Recipharm remains on track for growth. The Swedish CDMO is acquiring Italian injectable beta lactam expert...
Share
